These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 41416)

  • 21. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
    Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-acetylcholine receptor antibodies and myasthenia gravis (author's transl)].
    Nishitani H
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1578-83. PubMed ID: 7229476
    [No Abstract]   [Full Text] [Related]  

  • 26. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunisation with Torpedo acetylcholine receptor.
    Elfman L
    Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic and genetic factors in autoimmune diseases.
    Shoenfeld Y; Schwartz RS
    N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779
    [No Abstract]   [Full Text] [Related]  

  • 29. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to acetylcholine receptors in myasthenia gravis.
    N Engl J Med; 1983 Feb; 308(7):402-3. PubMed ID: 6823248
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunology of the acetylcholine receptor.
    Lennon VA
    Immunol Commun; 1976; 5(4):323-44. PubMed ID: 61167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Kirvan CA; Zhu S; Richman DP; Agius MA
    Ann N Y Acad Sci; 1998 May; 841():466-8. PubMed ID: 9668275
    [No Abstract]   [Full Text] [Related]  

  • 33. Coimmunization of MHC class II competitor peptides during experimental autoimmune myasthenia gravis induction resulted not only in a suppressed, but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; Van Eden W; De Baets MH
    Ann N Y Acad Sci; 1998 May; 841():338-41. PubMed ID: 9668254
    [No Abstract]   [Full Text] [Related]  

  • 34. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T; Yeh TM; Krolick KA
    J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
    J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Graus YM; Theunissen RO; Yamamoto T; Vincent A; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1992 Feb; 36(2-3):117-25. PubMed ID: 1732277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 40. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.